Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Hatlen (Trondheim, Norway). Late Breaking Abstract - Use of inhaled corticosteroids and the risk of lung cancer, the HUNT study. 4197

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016 Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Late Breaking Abstract - Cardiovascular risk and COPD in a population-based study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021 Late Breaking Abstract - SABA overuse and risk of mortality in a nationwide Swedish asthma cohort (HERA) Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018 Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018 Year: 2019 Late Breaking Abstract - Dietary patterns and lung function in a case-control study of asthma in Italian adults. Source: International Congress 2019 – More and more COPD Year: 2019 Late Breaking Abstract - Occupational exposure to disinfectants and COPD incidence in US nurses: a prospective cohort study Source: International Congress 2017 – The air indoor air pollution Year: 2017 Incidence of lung cancer in smokers with and without COPD: Observational study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Late Breaking Abstract - The association of osteoporosis with mortality and symptom burden in a COPD cohort. The HUNT Study, Norway. Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Oral corticosteroid (OCS) risk predictor for osteoporosis Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Late Breaking Abstract - Ultraviolet radiation and lung function in aging women: A European multi-centre study (ECRHS) Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019 Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020 Year: 2021 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients. Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019